Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS.
about
Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma.Predicting early intrahepatic recurrence of hepatocellular carcinoma after microwave ablation using SELDI-TOF proteomic signature.Advances in Proteomic Technologies and Its Contribution to the Field of CancerBiomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9.
P2860
Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Discovery of diagnostic biomar ...... epleted serum by SELDI-TOF MS.
@ast
Discovery of diagnostic biomar ...... epleted serum by SELDI-TOF MS.
@en
Discovery of diagnostic biomar ...... epleted serum by SELDI-TOF MS.
@nl
type
label
Discovery of diagnostic biomar ...... epleted serum by SELDI-TOF MS.
@ast
Discovery of diagnostic biomar ...... epleted serum by SELDI-TOF MS.
@en
Discovery of diagnostic biomar ...... epleted serum by SELDI-TOF MS.
@nl
prefLabel
Discovery of diagnostic biomar ...... epleted serum by SELDI-TOF MS.
@ast
Discovery of diagnostic biomar ...... epleted serum by SELDI-TOF MS.
@en
Discovery of diagnostic biomar ...... epleted serum by SELDI-TOF MS.
@nl
P2093
P1433
P1476
Discovery of diagnostic biomar ...... depleted serum by SELDI-TOF MS
@en
P2093
Liping Chung
Ross C Smith
P304
P356
10.1016/J.PAN.2012.02.009
P577
2012-02-21T00:00:00Z